ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuso Pharmaceutical Industries,Ltd.
  3. Financials
  4. Pretax margin (%)

Fuso Pharmaceutical Industries,Ltd. (4538)

Market cap
¥19.6B
P/E ratio
13.6x
Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 20263.8-39.60%
Mar 31, 20256.2+85.13%
Mar 31, 20243.4-22.35%
Mar 31, 20234.3+7.96%
Mar 31, 20224-11.06%
Mar 31, 20214.5+98.95%
Mar 31, 20202.3-18.13%
Mar 31, 20192.8+53.15%
Mar 31, 20181.8+32.09%
Mar 31, 20171.4+265.04%
Mar 31, 20160.4-73.92%
Mar 31, 20151.4-74.18%
Mar 31, 20145.6-27.62%
Mar 31, 20137.7+4519.40%
Mar 31, 20120.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat